Insiders who reported open-market trades in the last 12 months at the companies John W. Childs files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
John W. Childs is a corporate insider, tracked as Director of Veradermics, Inc (MANE). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John W. Childs submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John W. Childs been buying or selling stock?
Recorded transactions: 6 open-market purchases ($37.91M) and 3 open-market sales ($10.71M) across all tracked filings.
John W. Childs is Director of Veradermics, Inc (MANE). 9 SEC Form 4 filings on record going back to 2024, most recently on 14 August 2026. Most recent open-market trade: sold $541K of MANE on 14 August 2026. Lifetime open-market purchases: $37.91M. Lifetime open-market sales: $10.71M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by John W. Childs.
InsiderAlpha's records for John W. Childs go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $6.32M (6 buys totaling $37.91M). The largest single buy on record is $25.00M of BHVN in 2025. Sales side: 3 recorded sales totaling $10.71M, so the filing history runs buy-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
